The financing consists of $15 million in private equity, with Creation Capital of New York and Austin, Texas, acting as the placement agent, and $15 million in debt facility provided by Zion First National Bank in Salt Lake City.
Amedica completed transactions in excess of $100 million in the recent past to grow the company’s technology assets and value. Over the last six quarters, the company has shown a 24 percent increase in the spinal implant business.
Read the release on financing for Amedica.
Read other coverage on Amedica:
– Amedica Receives Patent for Knee Prosthesis
– Amedica Partners With SUNY Upstate Medical University to Research SiN Ceramic Technology
– Trends and Developments Shaping the Future of Spine: Q&A With Ben Shappley of Amedica
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
